Lagatar24.com
Language : HINDI
  • Home
  • Jharkhand
  • Bihar
  • National & World
  • Business
  • Health & Lifestyle
  • Sports
  • Entertainment
  • Career
  • Tech – Gyan
  • Opinion
Thursday, 12 June, 2025
Lagatar24.com
  • Home
  • Jharkhand
  • Bihar
  • National & World
  • Business
  • Health & Lifestyle
  • Sports
  • Entertainment
  • Career
  • Tech – Gyan
  • Opinion
Lagatar24.com
No Result
View All Result
  • Home
  • Jharkhand
  • Bihar
  • National & World
  • Business
  • Health & Lifestyle
  • Sports
  • Entertainment
  • Career
  • Tech – Gyan
  • Opinion
Home Corona

Corbevax booster shot approved for 18+ vaccinated with Covaxin, Covishield

Lagatar News by Lagatar News
August 10, 2022
in Corona
Share on FacebookShare on Twitter

 

Lagatar24 Desk

 

New Delhi, Aug 10: The government has approved Biological E’s Corbevax as a booster dose or precaution dose for adults above18 who have had both the Covishield and Covaxin vaccines.

This is the first time a different booster dose than the one used for the primary Covid vaccination has been authorised in the nation.

According to the sources cited by Press Trust of India, the recent recommendations provided by the COVID-19 Working Group of the National Technical Advisory Group on Immunization served as the foundation for the Union Health Ministry’s acceptance (NTAGI).

According to the sources, this will be in addition to the current recommendations for administering homologous prophylactic doses of the Covaxin and Covishield vaccines. On the Co-WIN portal, all essential adjustments are being made in relation to the delivery of the precautionary dosage of the Corbevax vaccination.

Corbevax, the country’s first RBD protein subunit vaccine, is presently administered to youngsters between the ages of 12 and 14 as part of the COVID-19 immunisation programme.

 

ALSO READ: Congress leader Priyanka Gandhi tests Covid positive

 

In its meeting on July 20, the COVID-19 Working Group (CWG) reviewed data from the double-blind randomised phase-3 clinical study that assessed the immunogenicity and safety of a booster dose of the Corbevax vaccine when given to adult volunteers aged 18 to 80 who had previously received two doses of either Covishield or Covaxin.

On June 4, the Drugs Controller General of India (DCGI) approved Corbevax as a precautionary dose for individuals 18 years of age and above. Indian healthcare and frontline workers, as well as the people above 60 years, started receiving precautionary vaccination doses from January 10. On April 10, India started giving COVID-19 booster doses or prophylactic doses to all adults over the age of 18.

Share76Tweet47
Previous Post

If I hurt anyone, I regret it, says Aamir Khan on ‘boycott Laal Singh Chaddha’ trend

Next Post

SC grants bail to activist Varavara Rao in Bhima Koregaon case

Related Posts

Amid rise in Covid cases, nationwide mock drill from today to check preparedness

April 10, 2023

Centre asks states to ensure availability of oxygen, functional life support equipment at hospitals

December 24, 2022

No need to block international flights or enforce lockdown in India yet: Experts

December 24, 2022

China estimates 37 million Covid cases in a day: Report

December 23, 2022

India plans to make Covid-19 negative test mandatory for passengers from high caseload countries

December 23, 2022

Covid Alert: Vaccination resumes in Jamshedpur, masks mandatory in govt hospitals

December 23, 2022
Load More

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • About Editor
  • Advertise with us
  • Privacy Policy
  • Contact Us

© 2024 Lagatar News (Lagatar24.com)

No Result
View All Result
  • Home
  • Jharkhand
  • Bihar
  • National & World
  • Business
  • Health & Lifestyle
  • Sports
  • Entertainment
  • Career
  • Tech – Gyan
  • Opinion

© 2024 Lagatar News (Lagatar24.com)